| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.9 |